Dr. Susanne Resatz, formerly Manager Process Development and Manufacturing at Vetter's clinical development facility in Chicago, Illinois, has assumed the role of President. Resatz will be fully responsible for the site's operations. Dr. Claudia Roth, who held this position before, will repatriate to the company headquarters in Ravensburg, Germany where she will head up the newly created "Innovation" department. Both Resatz and Roth have been with Vetter's US facility since its opening in 2009, and were instrumental in its early construction through to its becoming fully operational in October 2011. Resatz's expertise includes designing and implementing highly efficient, high-quality manufacturing processes for early-stage products. She holds a PhD in biomedical engineering from the Vienna University of Technology.

Vetter also announced that Dr. Paul Nelles, who headed Vetter´s global Development Service activities, will take early retirement after 11 years of service with Vetter. His replacement, Dr. Claus Feussner, formerly vice president Quality Control, has assumed the title of senior vice President of Vetter Development Service effective September 1. Nelles will continue with his efforts at Vetter until mid-2015 to help with the transition.